Westminster oncology company holds first earnings call since going public


The oncology therapeutics company increased its investment in research and development to $9.4 million this quarter.

Previous Peninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'
Next Denver beer spa expands to suburbs with new location